Paschalis Evangelidis/LinkedIn
Jul 9, 2026, 12:19
Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
Paschalis Evangelidis, Medical Doctor, Former Teaching Assistant at Aristotle University of Thessaloniki (AUTH), shared a post on LinkedIn:
“We would like to share that the submission deadline for our Special Issue in Pharmaceuticals MDPI has been extended to 25 January 2027.
We warmly welcome contributions from colleagues working on thrombosis, thrombotic microangiopathies, endothelial injury syndromes, cardiovascular disease, inflammation, and related scientific fields.
More information is available here.”
Stay updated with Hemostasis Today.
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
-
Jul 9, 2026, 11:54Deepak Pradhan։ Can Withaferin-A Help Combat Drug-Resistant Malaria?
-
Jul 9, 2026, 11:26Peter Zhang: Is Canada Ready for the Gene Therapy Era?
-
Jul 9, 2026, 09:35Pradeebha Muthukumar: Do You Know the Signs of Anemia?
-
Jul 9, 2026, 09:24Maryam Majid: Machine Learning for Anemia Risk Prediction
-
Jul 9, 2026, 08:46Jordan Agay: Folate Deficiency in Patients Receiving PARP Inhibitors
-
Jul 9, 2026, 08:29Laura Katz: Is Human Lactoferrin Better Than Bovine Lactoferrin?
-
Jul 9, 2026, 08:17Anziya Sabeer: AI-Driven Non-Invasive Anemia Detection